Chronic drooling is involuntary release of saliva from the mouth. Drooling can take place due to different medical conditions that lead to impairment of neuromuscular control of muscles around the mouth. These medical conditions weaken the muscles in and around the mouth, which increases salivation. An example of neuromuscular loss of control is cerebral palsy, wherein the oral neuromuscular control is affected. This leads to involuntary drooling. Some other prominent medical conditions that may result in drooling are autism, ALS, Down syndrome, stroke, and Parkinson's disease. Drooling is common in infants due to undeveloped muscular control. Drooling is medically of two types: ptyalism and sialorrhea. A few prominent causes of drooling include strep throat, infectious mononucleosis, sinus infections, and peritonsillar abscess formation. The treatment of patients suffering from drooling can be successfully carried out in health care centers by a physical therapist, pediatric dentist, otolaryngologist, and speech pathologist. The treatment for drooling comprises medical management for correcting the oral motor dysfunction and assisting in decreasing the volume of salivary gland secretion.

The oral motor training for chronic drooling aims at restoring excessive drooling in patients suffering from cerebral palsy, it also including lack of muscle quality affecting position of the head and in patients suffering from oral dysfunction effects the of swallowing. During the oral motor training, different exercises are used in an attempt to restore muscle quality; help stabilize head and body position of the patient to increase the stability of the jaw; help increase the oral sensation; and support swallowing. This oral motor training therapy is generally implemented by an occupational therapist, physical therapist, and speech pathologist. Behavioral therapy is used to treat patients suffering from excessive drooling by increasing the swallowing efficiency of the patient and increasing awareness about mouth and its functions.

Medication can be employed for the treatment of chronic drooling. It includes use of anticholinergics, which act as inhibitors at muscarinic receptors. This, in turn, reduces drooling. The secondary effect of the drug leads to limiting the treatment. Secondary effects of the treatment include restlessness and sedation. The first liquid medication for the treatment of drooling approved by the FDA was Cuvposa, which was introduced in the U.S. market in April 2011. In some cases, surgery can be performed to reduce the saliva secretion by re-routing the salivary glands or relocating them in such a way that saliva is released at the back end of the mouth. This makes it easier for the patient to swallow.

The global chronic drooling treatment market is anticipated to expand at a significant CAGR during the forecast period. The increasing number of patients suffering from some form of neurological disorders, increasing geriatric population, rising prevalence of chronic drooling in children, and growing awareness in developing economies are anticipated to drive the global chronic drooling treatment market during the forecast period. On the other hand, lack of precise therapy or treatment type, lack of proper health care facilities in smaller economies, and adverse side-effects associated with certain medications are restraining the global chronic drooling treatment market.

Geographically, the global chronic drooling treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to hold a major share of the global chronic drooling treatment market during the forecast period, due of better access to health care facilities, higher awareness about chronic drooling, high number of screening procedures, and presence of leading drug manufacturers in the region.

North America was closely followed by Europe and Asia Pacific. Asia Pacific is an emerging market for chronic drooling treatment, largely due to increasing health care expenditure, increasing population, and growing awareness in the region.

Latin America and Middle East & Africa are expected to offer lucrative growth opportunities to the chronic drooling treatment market, due to increased health care expenditure by governments, risen awareness regarding chronic drooling, and increased public–private partnerships to promote research and development activities for treatment of chronic drooling in the region.  

Major players operating in the global chronic drooling treatment market include Shionogi Inc., Ipsen Group, Orient Pharma Co., and Proveca.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Chronic Drooling Treatment Market

Pre Book